Philips Launches New Cardiology Ultrasound System and Clinical Resources at European Society of Cardiology Meeting; System and technology innovation reinforce Philips leadership in cardiology

Royal Philips Electronics (NYSE: PHG; AEX: PHI) todaylaunched the new Philips HD11 XE cardiology ultrasound system tocoincide with the first day of Europe's largest cardiology conference,the European Society of Cardiology, hosted in Stockholm. Seen for thefirst time by cardiologists worldwide, the system is the latestversion of the popular HD11 ultrasound system with a flat panelmonitor, and is designed to meet the specific needs of cardiologiststhrough more powerful cardiac capabilities that allow advancedquantification to make faster and more specific treatment decisions.

Philips HD11 XE

The new Philips HD11 XE adds a variety of features to helpphysicians more accurately measure heart chambers, wall motion andejection fraction. The system also features QLAB quantificationsoftware to help physicians improve their diagnostic capability byproviding non-invasive assessment of cardiac anatomy and function,including:

-- Strain Quantification, using Tissue Doppler Imaging (TDI) provides tools to quantify velocity and evaluate patients for synchronization therapy

-- Automated intima media thickness (IMT) measurements of carotid and other superficial arteries

-- Region of Interest (ROI) quantification to analyze pixel intensities from 2D or colour Doppler data sets in up to 10 user-defined regions, and graph them over time

The Philips HD11 XE system was designed to meet the growing needof many healthcare institutions for a cardiovascular ultrasound systemthat can quickly handle the scanning needs of a widely divergentpatient population and the increasing demand for echo examinations.

1,000th iE33 system shipped As of September 1, 2005 PhilipsMedical Systems has shipped more than 1,000 iE33 intelligentechocardiography systems throughout the world. The popular ultrasoundsystem reached this key milestone less than eleven months after itsintroduction, in October 2004.

The Philips iE33 is a new generation of cardiac ultrasoundequipment that uses high-definition imaging to help physicians betterdiagnose heart disease and incorporates data analysis tools to helpsupport treatment decisions and monitor treatment success. Physiciansaround the world have praised the Philips iE33 for its extraordinary2-D image quality, powerful 3-D measurement of cardiac function andanatomy, Live 3D imaging of the beating heart, and user-centricergonomics. The iE33 system also offers a wide range ofhigh-performance features including voice-activated control andautomated image optimization technologies.

"The Philips iE33 is a demonstration of the expanding role ofultrasound in the management of cardiac patients. Now physicians havethe tools to look at the heart beating in three dimensions and make amore accurate measure of heart function, in less than a minute." saidKurt Kelln, director, ultrasound, for Philips Medical Systems, Europe.

"The growing number of heart failure patients and the need foreconomical care solutions are a challenge for physicians. Ourcommitment to giving them what they need to more accurately diagnose,make treatment decisions and monitor treatment is reflected in thepopularity of the iE33," said Barbara Franciose, CEO, ultrasound, forPhilips Medical Systems.

Philips ST Map

ST Map is a new addition to the growing set of clinical decisionsupport tools available on Philips IntelliVue patient monitors.

Continuous ST segment monitoring - the ST segment is the portionof the electrocardiographic tracing that can indicate myocardialischemia, or less-than-normal blood flow to the heart. - is acceptedas a sensitive detector of myocardial ischemia. However, standardtabular displays of the data can be difficult for clinicians tointerpret. Philips new ST Map graphical display is designed around theclinician. It displays a mind's-eye-view of ST segment changes, withthe goal of helping clinicians recognize patterns and track patientprogress more easily.

New QLAB Synchronicity Indices Software release

The unique capability of the Philips iE33 echocardiography systemto accurately measure the wall motion in 17 different segments of theheart has been further enhanced with the addition of a 3D"synchronicity indices" that can help determine those patients whowould best benefit from cardiac resynchronization therapy (theimplantation of a pacemaker).

The indices, developed by leading cardiac physicians around theworld, draw clinical data from scores of CRT cases to identifyprobable success scenarios. The QLAB software uses livethree-dimensional data of the heart to measure and compare the time tomaximum contraction of the left ventricle--a key indicator of hearthealth.

Philips products and technologies will be displayed at ESC booths,

For further information please contact:

Heidi Wilson

Tel: +1 978 659 7302

Heidi.Wilson@philips.com

Steve Kelly

Tel: +1 425 487 7479

Steve.Kelly@philips.com

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI)is one of the world's biggest electronics companies and Europe'slargest, with sales of EUR 30.3 billion in 2004. With activities inthe three interlocking domains of healthcare, lifestyle and technologyand 159,700 employees in more than 60 countries, it has marketleadership positions in medical diagnostic imaging and patientmonitoring, color television sets, electric shavers, lighting andsilicon system solutions. News from Philips is located atwww.philips.com/newscenter.